La gestione della TAO con i nuovi farmaci anticoagulanti orali: una nuova frontiera, in Rivaroxaban per la prevenzione dell’ictus in pazienti con fibrillazione atriale: risultati di una valutazione di HTA

Translated title of the contribution: [Autom. eng. transl.] TAO management with new oral anticoagulant drugs: a new frontier in Rivaroxaban for stroke prevention in patients with atrial fibrillation: results of an HTA assessment

Maria Lucia Specchia, Chiara Cadeddu, Gualtiero Ricciardi, Silvio Capizzi, Anna Maria Ferriero, Agostino Mancuso, Chiara De Waure, Giuseppe La Torre, Flavia Kheiraoui

Research output: Working paper

Fingerprint

Dive into the research topics of '[Autom. eng. transl.] TAO management with new oral anticoagulant drugs: a new frontier in Rivaroxaban for stroke prevention in patients with atrial fibrillation: results of an HTA assessment'. Together they form a unique fingerprint.

Medicine & Life Sciences